India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
Product Overview
Sanjar Pharma manufactures Enoxaparin Sodium Injection 60mg/0.6ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured under controlled conditions using validated pharmaceutical processes and strict quality management systems.
Enoxaparin Sodium is a Low Molecular Weight Heparin (LMWH) widely utilized in anticoagulant therapy. The prefilled syringe presentation supports accurate dosing, simplified administration, and reduced preparation requirements in clinical and hospital environments.
Supported by advanced manufacturing infrastructure, quality assurance programs, analytical laboratories, and microbiological testing facilities, Sanjar Pharma supplies Enoxaparin Sodium Injection to pharmaceutical companies, distributors, healthcare institutions, and international procurement organizations.
Technical Specifications
Generic Name
Enoxaparin Sodium
Strength
60mg/0.6ml
Brand Name
SP-NOX
Therapeutic Category
Anticoagulants
Dosage Form
Prefilled Syringe (PFS)
Route of Administration
Subcutaneous Injection
Product Type
Sterile Injectable
Manufacturing Standard
WHO-GMP
Supply Type
Commercial Supply
Contract Manufacturing
Available
Third Party Manufacturing
Available
Regulatory Documentation
Available Upon Request
Storage Condition
As Per Approved Product Specifications
Export Supply
Available
Advanced Sterile Injectable Manufacturing
Sanjar Pharma operates a modern sterile injectable manufacturing facility equipped with advanced production, testing, quality assurance, and environmental control systems designed to support international pharmaceutical supply requirements.